
浏览全部资源
扫码关注微信
辽宁中医药大学附属第四医院急诊科
纸质出版日期:2021,
扫 描 看 全 文
杨永, 徐靖华, 郑珂, 等. 自拟平喘固本方联合噻托溴铵对稳定期COPD患者肺功能、血清学指标的影响[J]. 保健医学研究与实践, 2021,18(3):80-83.
Yang Yong, Xu Jinghua, Zheng Ke, et al. Effects of self-developed pacifying and consolidating formula combined with tiotropium bromide on pulmonary function and serological indexes in stable COPD patients[J]. Health Medicine Research and Practice, 2021,18(3):80-83.
杨永, 徐靖华, 郑珂, 等. 自拟平喘固本方联合噻托溴铵对稳定期COPD患者肺功能、血清学指标的影响[J]. 保健医学研究与实践, 2021,18(3):80-83. DOI:
Yang Yong, Xu Jinghua, Zheng Ke, et al. Effects of self-developed pacifying and consolidating formula combined with tiotropium bromide on pulmonary function and serological indexes in stable COPD patients[J]. Health Medicine Research and Practice, 2021,18(3):80-83. DOI:
目的探讨自拟平喘固本方联合噻托溴铵对稳定期慢性阻塞性肺疾病(COPD)患者肺功能、血清学指标的影响。方法采用随机数字表法将2017年3月-2019年3月辽宁省某医院诊治的102例稳定期COPD患者分为研究组和对照组
每组51例。对照组患者给予噻托溴铵治疗
研究组患者在对照组基础上联用自拟平喘固本方治疗。比较2组患者的临床疗效、不良反应发生情况;比较2组患者治疗前后最大呼气流量(PEF)、第1秒用力呼气容积占预计值百分比(FEV1%预计值)、用力肺活量(FVC)
血清肿瘤坏死因子α(TNF-α)、基质金属蛋白酶9(MMP-9)水平
以及动脉血二氧化碳分压(Pa CO
2
)、动脉血氧分压(PaO
2
)水平。结果研究组患者治疗总有效率为96.08%
高于对照组的82.35%
差异有统计学意义(P
<
0.05)。治疗前
2组患者PEF、FEV
1
%预计值、FVC比较
差异均无统计学意义(P
>
0.05);治疗后
2组患者PEF、FEV
1
%预计值、FVC均高于治疗前且研究组高于对照组
差异均有统计学意义(P
<
0.05)。治疗前
2组患者PaCO
2
及PaO
2
比较
差异均无统计学意义(P
>
0.05);治疗后
2组患者PaCO
2
均低于治疗前
PaO
2
均高于治疗前
差异均有统计学意义(P
<
0.05);治疗后
研究组患者PaCO
2
低于对照组
PaO
2
高于对照组
差异均有统计学意义(P
<
0.05)。治疗前
2组患者血清TNF-α、MMP-9水平比较
差异均无统计学意义(P
>
0.05);治疗后
2组患者血清TNF-α、MMP-9水平均低于治疗前
且研究组低于对照组
差异均有统计学意义(P
<
0.05)。2组患者不良反应发生率比较
差异无统计学意义(P
>
0.05)。结论自拟平喘固本方联合噻托溴铵能提高稳定期COPD患者的临床疗效
改善肺功能
降低炎症因子水平
且安全性较好。
Objective To investigate the effects of self-developed pacifying and consolidating formula combined with tiotropium bromide on pulmonary function and serological indexes in patients with stable chronic obstructive pulmonary disease(COPD).Methods One hundred and two patients with stable COPD treated in a hospital in Liaoning from March 2017 to March 2019 were divided into a study group and a control group using a random number table
with 51 cases in each group.Patients in the control group were treated with tiotropium bromide
and patients in the study group were treated with self-developed pacifying and consolidating formula in addition.The clinical efficacy and adverse effects of the two groups were compared;the peak expiratory flow(PEF)
the predicted Tiffeneau-Pinelli index(FEV1% predicted)
the forced vital capacity(FVC)
the serum tumor necrosis factor a(TNF-α) and matrix metalloproteinase 9(MMP-9) levels
and the arterial blood carbon dioxide partial pressure(PaCOz) and arterial blood oxygen partial pressure(PaO
2
) were compared before and after treatment.Results The total effective rate of treatment for patients in the study group was 96.08%
which was higher than that of the control group(82.35%)
and the difference was statistically significant(P
<
0.05).Before treatment
the differences in PEF
FEV1% predicted and FVC were not statistically significant(P
>
0.05);after treatment
PEFFEV
1
% predicted and FVC were higher in the two groups than before treatment and higher in the study group than in the control group.All differences were statistically significant(P
<
0.05).Before treatment
there was no statistically significant difference in PaCO2 and PaO2 between the two groups(P
>
0.05);after treatment
PaCO2 was lower than before treatment and PaO2 was higher than before treatment in both groups
and the difference was statistically significant(P
<
0.05);after treatment
PaCO2 in the study group was lower than the control group and PaO2 in the study group was higher than the control group
and the difference was statistically significant(P
<
0.05).Before treatment
there was no statistically significant differences between the serum TNF-α and MMP-9 levels of the two groups(P
>
0.05);after treatment
the serum TNF-αand MMP-9 levels of the two groups were lower than before treatment
and those in the study group were lower than those in the control group.The differences were statistically significant(P
<
0.05).Conclusion The combination of self-developed pacifying and consolidating formula and tiotropium bromide can improve clinical efficacy
improve lung function
and reduce inflammation level in stable COPD patients with sufficient safety.
自拟平喘固本方噻托溴铵慢性阻塞性肺疾病临床疗效
Self-developed pacifying and consolidating formulaTiotropium bromideChronic obstructive pulmonary diseaseClinical efficacy
0
浏览量
21
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621